CT
Thouverey, Cyril
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis | Journal of bone and mineral research |  | 2026 | 6 | 27 | ||
| Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | | 2024 | 122 | 156 | ||
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | 2024 | 87 | 93 | ||
| Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | | 2021 | 426 | 537 | ||
| PDGF receptor signaling in osteoblast lineage cells controls bone resorption through upregulation of csf1 expression | Journal of Bone and Mineral Research |  | 2020 | 292 | 1 | ||
| Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | | 2018 | 469 | 3 | ||
| Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone | Journal of bone and mineral research | | 2016 | 395 | 4 | ||
| Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro | BoneKEy reports | | 2015 | 474 | 7 | ||
| Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency | Endocrinology | | 2015 | 471 | 3 | ||
| Focus on the p38 MAPK signaling pathway in bone development and maintenance | BoneKEy reports | | 2015 | 615 | 4 | ||
| Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells | Molecular and cellular endocrinology | | 2014 | 690 | 1 | ||
| Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation | Journal of bone and mineral research | | 2013 | 699 | 545 | ||
| Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells | Biochemical and biophysical research communications | | 2012 | 573 | 0 | ||
| The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition | Cellular and molecular life sciences | | 2012 | 615 | 533 | ||
| Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth | Cellular physiology and biochemistry | | 2011 | 660 | 510 | ||
| Discovering the multiple roles of the p38 pathway in bone biology | IBMS boneKEy | | 2010 | 610 | 1 |
